Accelerating vaccine development for the fight against COVID-19

“Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts around Europe and the world – and TRANSVAC2 is well positioned to facilitate such efforts.”

Learn how TRANSVAC2 is supporting the Present and transforming the Future of European vaccine R&D landscape not only by answering pressing healthcare challenges as the COVID-19 pandemic, but also in positioning Europe as a global leader in vaccine R&D, in the latest EU Science, Research and Innovation success story.

For the full article:

TRANSVAC2 Success Story_200709
Download PDF • 826KB

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative